Lambda Therapeutic Research Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 04-11-2024
- Paid Up Capital ₹ 4.16 Cr
as on 04-11-2024
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.00 Cr
as on 04-11-2024
- Satisfied Charges ₹ 281.49 Cr
as on 04-11-2024
- Revenue 8.88%
(FY 2023)
- Profit -3.81%
(FY 2023)
- Ebitda -3.67%
(FY 2023)
- Net Worth 12.21%
(FY 2023)
- Total Assets 17.03%
(FY 2023)
About Lambda Therapeutic Research
The Corporate was formerly known as Lambda Therapeutic Research Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.16 Cr.
The company currently has active open charges totaling ₹22.00 Cr. The company has closed loans amounting to ₹281.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Binish Chudgar, Rikin Mody, Imran Ahmad, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24236GJ1998PLC034883
- Company No.
034883
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Oct 1998
- Date of AGM
15 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lambda Therapeutic Research?
Board Members(7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rikin Mody | Director | 14-Apr-2009 | Current |
Nikur Mody | Director | 16-Oct-2014 | Current |
Bindi Chudgar | Whole-Time Director | 06-Feb-2006 | Current |
Binish Chudgar | Director | 27-Oct-1998 | Current |
Imran Ahmad | Director | 17-Jul-2006 | Current |
Piyush Shah | Director | 01-Oct-2014 | Current |
Financial Performance and Corporate Structure Insights of Lambda Therapeutic Research.
Lambda Therapeutic Research Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.88% increase. The company also saw a slight decrease in profitability, with a 3.81% decrease in profit. The company's net worth Soared by an impressive increase of 12.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Lambda Therapeutic Research?
In 2023, Lambda Therapeutic Research had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Tfs Business Advisors India Private LimitedActive 18 years 10 months
Surender Kumar is a mutual person
- One Advertising And Communication Services LimitedActive 23 years 4 months
Bindi Chudgar is a mutual person
- Jina Pharmaceuticals Limited.Active 17 years 9 months
Binish Chudgar, Imran Ahmad and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 01 Jan 2009 | ₹5.00 Cr | Open |
Standard Chartered Bank Creation Date: 11 Apr 2008 | ₹5.00 Cr | Open |
Others Creation Date: 02 Sep 2004 | ₹12.00 Cr | Open |
How Many Employees Work at Lambda Therapeutic Research?
Lambda Therapeutic Research has a workforce of 987 employees as of Nov 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lambda Therapeutic Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lambda Therapeutic Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.